Aarey Drugs & Pharmaceuticals has informed that the Board of Directors of the Company, at its meeting held today, Thursday, March 6, 2025 based on the recommendation of Nomination and Remuneration Committee, approved the appointment of CS Kailash Chand Jethlia(Membership No.: F1476) as Company Secretary and Compliance Officer with effective from March 6, 2025 designated as the Key Managerial Personnel pursuant to the provisions of section 203 of the Companies Act, 2013 and Compliance Officer under Regulation 6(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Listing Regulations’). The details as required in terms of Regulation 30 read with Part A of Schedule III of the SEBI LODR and SEBI Circular No. SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023, is enclosed as Annexure-A. The meeting of the Board of Directors commenced at 04.00 pm and concluded at 04:30 pm.
The above information is a part of company’s filings submitted to BSE.